MedTrace Logo

Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

NCT03116191 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2018-04-13

No results posted yet for this study

Summary

The purpose of this trial is to demonstrate efficacy of SK-1404 against placebo for the treatment of subjects with nocturia due to nocturnal polyuria, during 4 weeks of treatment.

Conditions

  • Nocturia Due to Nocturnal Polyuria

Interventions

DRUG

SK-1404

4 weeks of repeated administration of SK-1404 to the patients of nocturia

DRUG

Placebo

4 weeks of repeated administration of Placebo to the patients of nocturia

Sponsors & Collaborators

  • Sanwa Kagaku Kenkyusho Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-23
Primary Completion
2017-12-15
Completion
2017-12-15

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03116191 on ClinicalTrials.gov